PathAI
AI-powered digital pathology platform for clinical diagnosis, biomarker discovery, and drug development companion diagnostics.
What it does
PathAI is an AI-native digital pathology company - providing AI-powered tools for pathologists to analyze whole slide images (WSIs) for disease diagnosis and for pharmaceutical companies to develop companion diagnostics and run clinical trials. AI capabilities include deep learning tissue analysis that identifies and quantifies cellular structures, tumor regions, and biomarker expression from digitized pathology slides, AI pathology quality control that flags technical slide preparation errors before diagnosis, companion diagnostic development that creates AI-based biomarkers for patient stratification in clinical trials, computational pathology models that quantify complex tissue characteristics that pathologists estimate subjectively, and AI-assisted diagnosis that provides pathologists with quantitative measurements supporting more reproducible diagnoses.
Why AI-NATIVE
PathAI is AI-native - deep learning computational pathology models that analyze tissue images for disease quantification and biomarker discovery are the core product architecture.
Best for
Large pharmaceutical companies use PathAI for companion diagnostic development - AI biomarker models enabling patient stratification in oncology clinical trials. Large health systems use PathAI for AI-assisted pathology diagnosis with quantitative tissue analysis.
Limitations
PathAI's AI operates on digitized whole slide images — pathology labs still using glass slide review need to invest in scanning infrastructure before AI-assisted digital pathology is applicable.
AI pathology tools require FDA clearance or CE marking for clinical use — PathAI models have different regulatory status by indication and geography, which buyers must verify for their specific clinical use case.
Paige.AI and Visiopharm offer competing AI pathology platforms — pharmaceutical and health system buyers should evaluate AI model accuracy, regulatory status, and workflow integration across these vendors.
Alternatives by segment
| If you need… | Consider instead |
|---|---|
| Digital pathology platform | Philips Digital Pathology |
| Drug discovery AI platform | Recursion |
PathAI enterprise contracts through pharmaceutical and health system partnerships. Not published. Annual contracts.
